Martin Bistrom
Umea, AC, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis.
Journal: Clinical & translational immunology
Published: February 26, 2026
Lytic Epstein-Barr virus infection and emerging autoantibodies precede multiple sclerosis prodrome.
Journal: Brain : a journal of neurology
Published: February 12, 2026
Human herpesvirus 7 and the risk of developing multiple sclerosis.
Journal: Brain communications
Published: September 02, 2025
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis.
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis.
Journal: European journal of neurology
Published: February 23, 2024
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study.
Journal: Annals of neurology
Published: January 30, 2024
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: May 21, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
Journal: Brain : a journal of neurology
Published: February 23, 2023
Systemic inflammation and risk of multiple sclerosis - A presymptomatic case-control study.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: May 18, 2022
Free vitamin D3 index and vitamin D-binding protein in multiple sclerosis: A presymptomatic case-control study.
Journal: European journal of neurology
Published: March 15, 2022
Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis.
Journal: Annals of clinical and translational neurology
Published: January 18, 2022
Cytomegalovirus seropositivity is associated with reduced risk of multiple sclerosis-a presymptomatic case-control study.
Journal: European journal of neurology
Published: March 02, 2021
Response to 'Mendelian randomization analysis does not support a role for leptin in multiple sclerosis'.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 15, 2020
Last Updated: 09/26/2026